Yin and Yang of nicotine: harmful during development, beneficial in adult patient populations ||  Nicotine has remarkably diverse effects on the brain. Being the main active compound in tobacco, nicotine can aversively affect brain development. However, it has the ability to act positively by restoring attentional capabilities in smokers...

Meta-analysis of the clinical effectiveness of traditional Chinese medicine formula Chaihu-Shugan-San in depression.

NMDA (N-methyl-D-aspartate) is the selective agonist that binds to NMDA receptors but not to other glutamate receptors. The NMDA receptor (NMDAR) is the predominant molecular device for controlling synaptic plasticity and memory function. The NMDAR is a type of ionotropic glutamate receptor. Activation of NMDA receptors requires binding of glutamate or aspartate (aspartate does not stimulate the receptors as strongly). In addition, NMDARs also require the binding of the co-agonist glycine.

NMDA (N-methyl-D-aspartate) is the selective agonist that binds to NMDA receptors but not to other glutamate receptors. The NMDA receptor (NMDAR) is the predominant molecular device for controlling synaptic plasticity and memory function. The NMDAR is a type of ionotropic glutamate receptor. Activation of NMDA receptors requires binding of glutamate or aspartate (aspartate does not stimulate the receptors as strongly). In addition, NMDARs also require the binding of the co-agonist glycine.

Anti-NMDA Receptor Encephalitis: A Rare Disease Story

Anti-NMDA Receptor Encephalitis: A Rare Disease Story

NMDA receptor antagonists are a class of anesthetics that work to antagonize, or inhibit the action of, the N-methyl d-aspartate receptor (NMDAR). They are used as anesthesia for animals and, less commonly, for humans; the state of anesthesia they induce is referred to as dissociative anesthesia. Memantine is an uncompetitive NMDA channel blocker. Memantine is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system by blocking NMDA glutamate…

Rewriting a Receptor’s Role - Synaptic molecule works differently than thought; may mean new therapeutic targets for treating Alzheimer’s disease.

"Anti-NMDA (N-methyl D-aspartate) receptor encephalitis is an acute form of encephalitis, potentially lethal but with high probability for recovery, caused by autoimmune reaction against NR1- and NR2-subunits of the glutamate NMDA receptor. Different descriptions and syndromal designations for this disease existed in the medical literature prior to 2007, when the cause was established and it received its current name."

Anti-NMDA receptor encephalitis: Recombinant immunofluorescence test for determination of antibodies against glutamate receptors - EUROIMMUN US, Inc.

Dallas Cowboy Amobi Okoye recovers from NMDA receptor encephalitis   Posted August 24, 2014  by Will McDow  in News

Dallas Cowboy Amobi Okoye recovers from NMDA receptor encephalitis - Autoimmune Encephalitis Alliance

What is Anti-NMDA Receptor Encephalitis? (In English, French & Spanish) - The Anti NMDA Receptor Encephalitis Foundation Inc. The Anti NMDA Receptor Encephalitis Foundation Inc.

Anti-NMDA receptor encephalitis is a disease occurring when antibodies produced by the body’s own immune system attack NMDA receptors in the brain.

CHILDREN with Anti NMDA Receptor Encephalitis - This is the best VIDEO that shows what the experience is like for a child.  It is very different from that of an adult.  From CTV news -  Mystery illness often misdiagnosed in kids: Anti NMDA Receptor Autoimmune Encephalitis

VIDEO from CTV news - Mystery illness often misdiagnosed in kids: Anti NMDA Receptor Autoimmune Encephalitis

Memory in autoimmune NMDA receptor encephalitis: an issue for B cells and patients  Memory in autoimmune NMDA receptor encephalitis: an issue for B cells and patients Restricted access Anastasia Zekeridou, Vanda A. Lennon DOI: http://dx.doi.org/10.1093/brain/aww213 2581-2583 First published online: 26 September 2016

Memory in autoimmune NMDA receptor encephalitis: an issue for B cells and patients

A ticking time bomb: Circulating anti-NMDA receptor autoantibodies -  Dr. Heike Benecke Presse- und Öffentlichkeitsarbeit

A ticking time bomb: Circulating anti-NMDA receptor autoantibodies

The similarity between NMDA receptor antagonist-induced psychosis and schizophrenia has led to the widespread use of the drugs to provide models to aid the development of novel treatments for the disorder.

N-methyL-D-aspartate (NMDA) receptor antagonists, such as ketamine and phencyclidine, induce perceptual abnormalities, psychosis-like symptoms, and mood changes

Study measures brain activity to predict outcomes for traumatic #braininjury #neuroskills

SickKids study measures brain activity to predict outcomes for traumatic brain injury

Pinterest
Search